GlassScriptPhysician profile
David Trinkley
NPI 1982764536
$4,278.96
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,506 · 2020: $482 · 2021: $370 · 2022: $921.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,110.38 | 2019-2022 | |
| Glaxosmithkline, LLC. | $413.49 | 2019-2022 | |
| Lilly USA, LLC | $353.46 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $349.97 | 2019-2021 | |
| Pfizer INC. | $349.63 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $199.73 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.83 | 2019-2022 | |
| Abbvie INC. | $162.15 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $157.22 | 2019-2022 | |
| Amarin Pharma, INC. | $150.08 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $146.58 | 2019-2020 | |
| Gilead Sciences, INC. | $139.94 | 2019-2022 | |
| Amgen INC. | $89.15 | 2019 | |
| Abbott Laboratories | $71.63 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $39.10 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $38.72 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $38.39 | 2019-2022 | |
| Astellas Pharma US INC | $37.53 | 2019-2022 | |
| Allergan, INC. | $36.74 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.41 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $29.40 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.01 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $28.35 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $19.04 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.58 | 2022 | |
| Eisai INC. | $14.24 | 2019 | |
| Genentech USA, INC. | $14.12 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.94 | 2019 | |
| Medtronic Minimed, INC. | $12.15 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Trinkley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.